Advanced or Recurrent Endometrial Cancer Clinical Trial
0 Pogledi
• 07/09/23
0
0
Ugraditi
administrator
Pretplatnici
The purpose of this clinical trial is to study the good and bad effects of adding the PD-1 inhibitor called pembrolizumab to standard treatment for advanced or recurrent endometrial cancer. http://www.bigtencrc.org
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari